Join Fenwick and the Life Science Washington Institute for a discussion on the key considerations surrounding the receipt and disclosure of clinical data in the life sciences sector. Our speakers Amanda Rose, Rob Freedman, and Chelsea Anderson will cover disclosure obligations, financing impacts, and best practices to ensure compliance and strategic advantage. This session is designed to provide valuable insights for business professionals navigating this complex landscape. This is a hybrid event that can be attended virtually or in person at our Seattle office.